Jennison Associates
DGX icon

Jennison Associates’s Quest Diagnostics DGX Stock Holding History

Jennison Associates’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,249
Closed -$207K – 682
2016
Q4 		$207K Buy
+2,249
New +$194K ﹤0.01% 798
2014
Q1 		– Sell
-55,037
Closed -$2.95M – 744
2013
Q4 		$2.95M Buy
+55,037
New +$3.26M ﹤0.01% 539

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jennison Associates's DGX Position: Q1 2017 in Review

Jennison Associates sold out of Quest Diagnostics (DGX) in Q1 2017, closing a stake of 2,249 shares — an estimated $207K sold.

Jennison Associates first reported a position in DGX in Q4 2013 and held it in 2 quarters. The position peaked at $2.95M in Q4 2013. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

  • Jennison Associates reported no remaining Quest Diagnostics position as of Q1 2017 after selling out during the quarter.
  • Jennison Associates sold 2,249 Quest Diagnostics shares in Q1 2017, an estimated $207K.
  • Jennison Associates first reported a position in Quest Diagnostics in Q4 2013 and held it in 2 quarters.
  • Jennison Associates's Quest Diagnostics position peaked at $2.95M in Q4 2013.
  • 614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on Jennison Associates's 13F filing for Q1 2017, filed 28 Apr 2017.